Quick Answer
Vor Biopharma Inc. reported Stockholders Equity of -$164.31 million for fiscal year 2025.
Vor Biopharma Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$164.31M | -270.0% |
| 2024 | $96.66M | -35.9% |
| 2023 | $150.72M | -39.9% |
| 2022 | $250.61M | +15.9% |
| 2021 | $216.26M | +466.1% |
| 2020 | -$59.06M | -238.9% |
| 2019 | -$17.43M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.23B | -3150.5% | -47.8% |
| June 30, 2025 | -$1.51B | -1635.2% | -2379.0% |
| March 31, 2025 | $66.07M | -46.3% | -31.7% |
| December 31, 2024 | $96.66M | -35.9% | +32.5% |
| September 30, 2024 | $72.95M | -58.3% | -25.6% |
| June 30, 2024 | $98.08M | -52.0% | -20.3% |
| March 31, 2024 | $123.03M | -46.6% | -18.4% |
| December 31, 2023 | $150.72M | -39.9% | -13.8% |
- Vor Biopharma Inc. showed a decrease of -270.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Vor Biopharma Inc.’s stockholders equity has declined by 842.8% (from -$17.43 million to -$164.31 million).
- The most recent figure is from Vor Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: